Mostrar el registro sencillo del ítem

dc.contributor.authorSanoguera-Miralles, Lara
dc.contributor.authorValenzuela-Palomo, Alberto
dc.contributor.authorBueno-Martínez, Elena
dc.contributor.authorEsteban-Sánchez, Ada
dc.contributor.authorLorca, Víctor
dc.contributor.authorLlinares-Burguet, Inés
dc.contributor.authorGarcía-Álvarez, Alicia
dc.contributor.authorPérez-Segura, Pedro
dc.contributor.authorInfante, Mar
dc.contributor.authorEaston, Douglas F
dc.contributor.authorDevilee, Peter
dc.contributor.authorVreeswijk, Maaike P G
dc.contributor.authorde la Hoya, Miguel
dc.contributor.authorVelasco-Sampedro, Eladio A
dc.date.accessioned2025-01-09T11:49:02Z
dc.date.available2025-01-09T11:49:02Z
dc.date.issued2024
dc.identifier.citationClinical Chemistry, Volume 70, Issue 1, January 2024, Pages 319–338es
dc.identifier.issn0009-9147es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/73288
dc.description.abstractBackground Disrupted pre-mRNA splicing is a frequent deleterious mechanism in hereditary cancer. We aimed to functionally analyze candidate spliceogenic variants of the breast cancer susceptibility gene CHEK2 by splicing reporter minigenes. Methods A total of 128 CHEK2 splice-site variants identified in the Breast Cancer After Diagnostic Gene Sequencing (BRIDGES) project (https://cordis.europa.eu/project/id/634935) were analyzed with MaxEntScan and subsetted to 52 variants predicted to impact splicing. Three CHEK2 minigenes, which span all 15 exons, were constructed and validated. The 52 selected variants were then genetically engineered into the minigenes and assayed in MCF-7 (human breast adenocarcinoma) cells. Results Of 52 variants, 46 (88.5%) impaired splicing. Some of them led to complex splicing patterns with up to 11 different transcripts. Thirty-four variants induced splicing anomalies without any trace or negligible amounts of the full-length transcript. A total of 89 different transcripts were annotated, which derived from different events: single- or multi-exon skipping, alternative site-usage, mutually exclusive exon inclusion, intron retention or combinations of the abovementioned events. Fifty-nine transcripts were predicted to introduce premature termination codons, 7 kept the original open-reading frame, 5 removed the translation start codon, 6 affected the 5′UTR (Untranslated Region), and 2 included missense variations. Analysis of variant c.684-2A > G revealed the activation of a non-canonical TG-acceptor site and exon 6 sequences critical for its recognition. Conclusions Incorporation of minigene read-outs into an ACMG/AMP (American College of Medical Genetics and Genomics/Association for Molecular Pathology)-based classification scheme allowed us to classify 32 CHEK2 variants (27 pathogenic/likely pathogenic and 5 likely benign). However, 20 variants (38%) remained of uncertain significance, reflecting in part the complex splicing patterns of this gene.es
dc.format.mimetypeapplication/pdfes
dc.language.isospaes
dc.publisherOxford Academices
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.titleSystematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variantses
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1093/clinchem/hvad125es
dc.identifier.publicationfirstpage319es
dc.identifier.publicationissue1es
dc.identifier.publicationlastpage338es
dc.identifier.publicationtitleClinical Chemistryes
dc.identifier.publicationvolume70es
dc.peerreviewedSIes
dc.identifier.essn1530-8561es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem